Extract from the Register of European Patents

EP About this file: EP2454250

EP2454250 - APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.11.2015
Database last updated on 11.04.2026
Most recent event   Tooltip20.11.2015No opposition filed within time limitpublished on 23.12.2015  [2015/52]
Applicant(s)For all designated states
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
[2012/21]
Inventor(s)01 / CORKEY, Britton
355 Buena Vista Ave East
Apt 415
San Francisco CA 94117 / US
02 / GRAUPE, Michael
1131 Banyan Way
Pacifica CA 94044 / US
03 / KOCH, Keith
384 Baker Lane
Erie CO 80516 / US
04 / MELVIN, Lawrence S.
7623 Crestview Drive
Longmont CO 80504 / US
05 / NOTTE, Gregory
707 Highland Ave Apt 2
San Mateo CA 94401 / US
 [2012/21]
Representative(s)Wallace, Sheila Jane, et al
Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[N/P]
Former [2015/03]Wallace, Sheila Jane, et al
Marks & Clerk LLP
90 Long Acre
London WC2E 9RA / GB
Former [2014/27]Wallace, Sheila Jane, et al
Marks & Clerk LLP 90 Long Acre London
WC2E 9RA / GB
Former [2012/21]Schnappauf, Georg, et al
Dr. Volker Vossius
Patent- und Rechtsanwaltskanzlei
Geibelstrasse 6
81679 München / DE
Application number, filing date10733116.712.07.2010
WO2010US41739
Priority number, dateUS20090289263P22.12.2009         Original published format: US 289263 P
US20090225076P13.07.2009         Original published format: US 225076 P
US20090225079P13.07.2009         Original published format: US 225079 P
[2012/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011008709
Date:20.01.2011
Language:EN
[2011/03]
Type: A1 Application with search report 
No.:EP2454250
Date:23.05.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 20.01.2011 takes the place of the publication of the European patent application.
[2012/21]
Type: B1 Patent specification 
No.:EP2454250
Date:14.01.2015
Language:EN
[2015/03]
Search report(s)International search report - published on:EP20.01.2011
ClassificationIPC:C07D401/12, C07D401/14, C07D407/14, C07D413/14, C07D471/04, C07D491/048, A61K31/437, A61K31/4439, A61K31/444, A61K31/497, A61K31/506, A61P9/00, A61P25/28, A61P29/00, A61P37/00
[2012/21]
CPC:
A61K31/444 (EP,US); C07D401/12 (EP,KR,US); A61K31/4196 (EP);
A61K31/4439 (EP,KR,US); A61K31/4709 (US); A61K31/496 (US);
A61K31/497 (US); A61K31/506 (EP,US); A61K31/5377 (US);
A61K31/585 (US); A61K45/06 (US); A61P25/28 (EP);
A61P29/00 (EP); A61P37/00 (EP); A61P9/00 (EP);
C07D401/14 (EP,US); C07D405/14 (US); C07D413/12 (US);
C07D413/14 (US); C07D417/14 (US); C07D471/04 (KR,US);
C07D491/048 (KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/21]
Extension statesBA10.02.2012
ME10.02.2012
RS10.02.2012
TitleGerman:APOPTOSESIGNALREGULIERENDE KINASEHEMMER[2012/21]
English:APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS[2012/21]
French:INHIBITEURS DE LA KINASE RÉGULANT LES SIGNAUX DE L'APOPTOSE[2012/21]
Entry into regional phase23.01.2012National basic fee paid 
23.01.2012Designation fee(s) paid 
23.01.2012Examination fee paid 
Examination procedure23.01.2012Amendment by applicant (claims and/or description)
23.01.2012Examination requested  [2012/21]
16.10.2012Despatch of a communication from the examining division (Time limit: M06)
02.04.2013Reply to a communication from the examining division
04.08.2014Communication of intention to grant the patent
03.12.2014Fee for grant paid
03.12.2014Fee for publishing/printing paid
03.12.2014Receipt of the translation of the claim(s)
Divisional application(s)EP15151030.2  / EP2933252
EP17208659.7  / EP3363797
EP20210819.7
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.10.2012
Opposition(s)15.10.2015No opposition filed within time limit [2015/52]
Fees paidRenewal fee
25.07.2012Renewal fee patent year 03
29.07.2013Renewal fee patent year 04
28.07.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I] EP2058309  (TAKEDA PHARMACEUTICAL et al.) [I] 1-36 * claims 1, 14-18 * * page 98 - page 99; examples 88, 89 * * page 1, paragraph [0001] * * ASK1 inhibitory activity; page 220 - page 221 *
by applicantUS2007276050
 US2007167386
 WO2009027283
 US3845770
 US4326525
 US4902514
 US5616345
 US5023252
 US4992445
 US5001139
   KUMAR, S.; BOEHM, J.; LEE., J.C., NAT. REV. DRUG DIS., vol. 2, 2003, pages 717 - 726
   PIMIENTA, G.; PASCUAL, J., CELL CYCLE, vol. 6, 2007, pages 2826 - 2632
   ICHIJO, H.; NISHIDA, E.; IRIE, K.; DIJKE, P. T.; SAITOH, M.; MORIGUCHI, T.; MATSUMOTO, K.; MIYAZONO, K.; GOTOH, Y., SCIENCE, vol. 275, 1997, pages 90 - 94
   HATTORI, K; NAGURO, I; RUNCHEL, C; ICHIJO, H, CELL COMM. SIGNA, vol. 7, 2009, pages 1 - 10
   TAKEDA, K.; NOGUCHI, T.; NAGURO, I.; ICHIJO, H., ANNU. REV. PHARMACOL. TOXICOL., vol. 48, 2007, pages 1 - 8.27
   NAGAI, H.; NOGUCHI, T.; TAKCDA, K.; ICHIJO, 1., J. BIOCHCM. MOL. BIOL., vol. 40, 2007, pages 1 - 6
   WANG, X. S.; DIENER, K.; TAN, T-H.; YAO, Z., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 253, 1998, pages 33 - 37
   TAKEDA, K.; SHIMOZONO, R.; NOGUCHI, T.; UMEDA, T.; MORIMOTO, Y.; NAGURO, I.; TOBIUME, K.; SAITOH, M.; MATSUZAWA, A.; ICHIJO, H., J. BIOL. CHEM., vol. 282, 2007, pages 7522 - 7531
   IRIYAMA, T. ET AL., EMBO J., vol. 28, 2009, pages 843 - 853
   SAITOH, M.; NISHITOH, H.; FUJI, M.; TAKEDA, K.; TOBIUME, K.; SAWADA, Y.; KAWABATA, M.; MIYAZONO, K.; LCHIJO, H., EMBO J., vol. 17, 1998, pages 2596 - 2606
   ZHANG, L.; CHEN, J.; FU, H., PROC. NATL. ACAD. SCI. U.S.A, vol. 96, 1999, pages 8511 - 8515
   WATANABE ET AL., BBRC, vol. 33, no. 3, 2005, pages 562 - 567
   ZHANG ET AL., LIFE SCI, 2003, pages 7443 - 37
   TERADA ET AL., BBRC, vol. 364, 2007, pages 1043 - 49
   FOSTER: "Deuterium Isotope Effects in Studies of Drug Metabolism", TRENDS PHARMACOL. SCI., vol. 5, no. 12, 1984, pages 524 - 527
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.